The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-(3R,5S)-{5-[(E)-2-({4'-Chloro-4-fluoro-[1,1'-biphenyl]-2-yl}methylidene)hydrazin-1-yl]piperidine-3-carboxylic acid} ID: ALA4447559
PubChem CID: 155518880
Max Phase: Preclinical
Molecular Formula: C19H19ClFN3O2
Molecular Weight: 375.83
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)[C@H]1CNC[C@@H](N/N=C/c2cc(F)ccc2-c2ccc(Cl)cc2)C1
Standard InChI: InChI=1S/C19H19ClFN3O2/c20-15-3-1-12(2-4-15)18-6-5-16(21)7-13(18)10-23-24-17-8-14(19(25)26)9-22-11-17/h1-7,10,14,17,22,24H,8-9,11H2,(H,25,26)/b23-10+/t14-,17+/m1/s1
Standard InChI Key: MATCLQIZQUZJIL-GOUPHMKNSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
7.5148 -9.6982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8004 -10.1152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0836 -9.7025 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3692 -10.1194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6525 -9.7066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6543 -8.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9383 -8.4734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2229 -8.8863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2280 -9.7161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9445 -10.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9511 -10.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2371 -11.3635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2430 -12.1883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9623 -12.5985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6770 -12.1737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6676 -11.3503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9697 -13.4242 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.9363 -7.6478 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.2247 -10.1130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9370 -9.6995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9389 -8.8735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2222 -8.4628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5079 -8.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2226 -7.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9383 -7.2225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5114 -7.2219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 1
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 11 1 0
14 17 1 0
7 18 1 0
1 19 1 0
1 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 1 1
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.83Molecular Weight (Monoisotopic): 375.1150AlogP: 3.13#Rotatable Bonds: 5Polar Surface Area: 73.72Molecular Species: ZWITTERIONHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.33CX Basic pKa: 8.99CX LogP: 1.03CX LogD: 1.02Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.55Np Likeness Score: -0.81
References 1. Hauke TJ, Höfner G, Wanner KT.. (2019) Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4., 27 (1): [PMID:30503411 ] [10.1016/j.bmc.2018.11.028 ]